BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3085103)

  • 1. A DNA insertion/deletion necessitates an aberrant RNA splice accounting for a mu heavy chain disease protein.
    Bakhshi A; Guglielmi P; Siebenlist U; Ravetch JV; Jensen JP; Korsmeyer SJ
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2689-93. PubMed ID: 3085103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein.
    Guglielmi P; Bakhshi A; Cogne M; Seligmann M; Korsmeyer SJ
    J Immunol; 1988 Sep; 141(5):1762-8. PubMed ID: 3137265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.
    Cogné M; Bakhshi A; Korsmeyer SJ; Guglielmi P
    J Immunol; 1988 Sep; 141(5):1738-44. PubMed ID: 3137264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the 3' splice site of the leader-variable region intron of immunoglobulin heavy chain genes induces a direct splicing of leader to constant region, resulting in the production of truncated mu-chains.
    Komori T; Sugiyama H
    Eur J Immunogenet; 1995 Jun; 22(3):241-7. PubMed ID: 8547230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion.
    Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL
    Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma heavy chain disease in man. Genomic sequence reveals two noncontiguous deletions in a single gene.
    Alexander A; Anicito I; Buxbaum J
    J Clin Invest; 1988 Oct; 82(4):1244-52. PubMed ID: 3139711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pre-translational defect in a case of human mu heavy chain disease.
    Bakhshi A; Guglielmi P; Coligan JE; Gamza F; Waldmann TA; Korsmeyer SJ
    Mol Immunol; 1986 Jul; 23(7):725-32. PubMed ID: 3099178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequence of immunoglobulin heavy chain joining segments between translocated VH and mu constant regions genes.
    Bernard O; Gough NM
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3630-4. PubMed ID: 6251474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of heavy chain genes for mouse immunoglobulins M and D.
    Liu CP; Tucker PW; Mushinski JF; Blattner FR
    Science; 1980 Sep; 209(4463):1348-53. PubMed ID: 6774414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts.
    Tuaillon N; Taylor LD; Lonberg N; Tucker PW; Capra JD
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3720-4. PubMed ID: 8475122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervening sequences divide the gene for the constant region of mouse immunoglobulin mu chains into segments, each encoding a domain.
    Gough NM; Kemp DJ; Tyler BM; Adams JM; Cory S
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):554-8. PubMed ID: 6767239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations in a case of alpha heavy chain disease leading to the generation of composite exons from the JH region.
    Bentaboulet M; Mihaesco E; Gendron MC; Brouet JC; Tsapis A
    Eur J Immunol; 1989 Nov; 19(11):2093-8. PubMed ID: 2513209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the cell-surface expression of immunoglobulin mu chain without light chain in human B lymphocytes.
    Pollok BA; Anker R; Eldridge P; Hendershot L; Levitt D
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9199-203. PubMed ID: 3122216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between fragmented immunoglobulin genes and heavy chain deletion mutants.
    Frangione B; Franklin EC
    Nature; 1979 Oct; 281(5732):600-2. PubMed ID: 114864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic rearrangements forming active immunoglobulin mu genes in B and T lymphoid cell lines.
    Cory S; Adams JM; Kemp DJ
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4943-7. PubMed ID: 6776532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The productive gene for alpha-H chain disease protein MAL is highly modified by insertion-deletion processes.
    Tsapis A; Bentaboulet M; Pellet P; Mihaesco E; Thierry D; Seligmann M; Brouet JC
    J Immunol; 1989 Dec; 143(11):3821-7. PubMed ID: 2555418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human heavy chain disease protein WIS: implications for the organization of immunoglobulin genes.
    Franklin EC; Prelli F; Frangione B
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):452-6. PubMed ID: 106391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
    Schlissel MS; Morrow T
    J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch.
    Kataoka T; Kawakami T; Takahashi N; Honjo T
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):919-23. PubMed ID: 6767246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate splice sites within the human VH gene coding sequences lead to truncated Ig mu-chains.
    Mounir S; Guglielmi P; Preud'homme J; Nau F; Cogné M
    J Immunol; 1990 Jan; 144(1):342-7. PubMed ID: 2104890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.